Favourable risk factor trends and improvements in therapy each explain about half the substantial decrease in coronary heart disease (CHD) mortality that has occurred in Ontario in recent years.
A lenient approach to heart rate control in atrial fibrillation (AF) is just as effective as the strict approach generally recommended in guidelines, Dutch researchers have found.
A Quebec study has shown many myocardial infarction patients are receiving reperfusion therapy outside recommended time windows, and this is putting them at increased risk of dying within 30 days.
